APA

Hartung G., Hofheinz R., Dencausse Y., Sturm J., Kopp-Schneider A., Dietrich G., Fackler-Schwalbe I., Bornbusch D., Gonnermann M., Wojatschek C., Lindemann W., Eschenburg H., Jost K., Edler L., Hochhaus A. & Queisser W. (20050823). Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study. : Onkologie.

Chicago

Hartung G, Hofheinz R-D, Dencausse Y, Sturm J, Kopp-Schneider A, Dietrich G, Fackler-Schwalbe I, Bornbusch D, Gonnermann M, Wojatschek C, Lindemann W, Eschenburg H, Jost K, Edler L, Hochhaus A and Queisser W. 20050823. Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study. : Onkologie.

Harvard

Hartung G., Hofheinz R., Dencausse Y., Sturm J., Kopp-Schneider A., Dietrich G., Fackler-Schwalbe I., Bornbusch D., Gonnermann M., Wojatschek C., Lindemann W., Eschenburg H., Jost K., Edler L., Hochhaus A. and Queisser W. (20050823). Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study. : Onkologie.

MLA

Hartung G, Hofheinz R-D, Dencausse Y, Sturm J, Kopp-Schneider A, Dietrich G, Fackler-Schwalbe I, Bornbusch D, Gonnermann M, Wojatschek C, Lindemann W, Eschenburg H, Jost K, Edler L, Hochhaus A and Queisser W. Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study. : Onkologie. 20050823.